367519-84-4

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-(hydroxyMethyl)-5-Methoxybenzoate is used as an intermediate in the synthesis of various medicines, contributing to the development of new pharmaceutical products.
Used in Perfume Production:
Methyl 3-(hydroxyMethyl)-5-Methoxybenzoate is used as a component in the production of perfumes, adding a sweet and aromatic scent to the final product.
Used in Flavoring Industry:
Methyl 3-(hydroxyMethyl)-5-Methoxybenzoate is used in the creation of flavorings for food products, enhancing their taste and aroma.
Used in Organic Chemistry:
Methyl 3-(hydroxyMethyl)-5-Methoxybenzoate is a versatile building block for the synthesis of various organic compounds, making it valuable in the field of organic chemistry.

Upstream product

• 71590-08-4 5-methoxy-isophthalic acid monomethyl ester 
• 618-83-7 5-Hydroxyisophthalic acid 
• 20319-44-2 dimethyl 5-methoxyisophthalate 
• 13036-02-7 Dimethyl 5-hydroxyisophthalate 

Downstream Products

• 69026-10-4 methyl 5-formyl-3-methoxybenzoate 
• 878743-98-7 3-methanesulfonyloxymethyl-5-methoxy-benzoic acid methyl ester 
• 1126431-84-2 methyl 5-methoxy-3-((tert-butyldimethylsilyl)oxymethyl)benzoate 
• 19254-84-3 1,3-di-(hydroxymethyl)-5-methoxybenzene 
• 878741-65-2 3-cyanomethyl-5-methoxy-benzoic acid methyl ester 
• 133357-62-7 methyl 3-(bromomethyl)-5-methoxybenzoate 
• 367519-88-8 5-formyl-3-methoxybenzoic acid 

Relevant academic research and scientific papers

HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES

The present invention provides compounds which antagonize hedgehog signaling and inhibit HDAC activity. The com-pounds can be used in methods of treating proliferative dis-eases and disorders such as cancer

Birch Reductive Alkylation of Methyl m-(Hydroxymethyl)benzoate Derivatives and the Behavior of o- and p-(Hydroxymethyl)benzoates under Reductive Alkylation Conditions

Birch reductive alkylation of methyl m-(hydroxymethyl)benzoate derivatives, using lithium in ammonia-tetrahydrofuran in the presence of tertbutyl alcohol, can be achieved without significant loss of benzylic oxygen substituents. Similar treatment of o- and p-(hydroxymethyl)benzoate derivatives results largely in loss of benzylic oxygen substituents. The results are rationalized by computations describing electron density patterns in the putative radical anion intermediate involved in these reactions.

THIAZOLE AND OXAZOLE KINASE INHIBITORS

The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.

COMPOSITIONS AND METHODS FOR FGF RECEPTOR KINASES INHIBITORS

Described are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent disease or disordered associated with abnormal or deregulated kinase activity, particularly diseases or disorders that

QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS

The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.

A practical and convenient synthesis of methyl 5-formyl-3-methoxybenzoate

A practical and convenient synthesis of methyl 5-formyl-3-methoxybenzoate starting from 3-hydroxy-5-(methoxycarbonyl)benzoate in 65% overall yield is described. Ethyl 5-formyl-3-methoxybenzoate was also prepared in the similar manner.